我的购物车

HEK293/Human PSMA Stable Cell Line

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车

产品详情

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • 描述(Description)

    The HEK293/Human PSMA Stable Cell Line was engineered to express the receptor full length human PSMA (Gene ID: 2346), used to mimic cancer target cells. Surface expression of human PSMA was confirmed by flow cytometry.

  • 应用说明(Application)

    • Useful for cell-based PSMA binding assay

  • 生长特性(Growth Properties)

    Adherent

  • 筛选标记(Selection Marker)

    Puromycin (2 μg/mL)

  • 培养基(Complete Growth Medium)

    DMEM + 10% FBS

  • 冻存液(Freeze Medium)

    Serum-free cell cryopreservation medium

  • 装量(Quantity)

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • 存储(Storage)

    Frozen in liquid nitrogen.

  • 支原体检测(Mycoplasma Testing)

    Negative

  • 无菌检测(Sterility Testing)

    Negative

  • 使用说明(Instructions for Use)

    See data sheet for detailed culturing and assay protocol.

产品展示

  • Receptor Assay

     PSMA FACS

    Expression analysis of human PSMA on HEK293/Human PSMA Stable Cell Line by FACS.
    Cell surface staining was performed on HEK293/Human PSMA Stable Cell Line or negative control cell using PE anti-human PSMA antibody after fixation with 4% paraformaldehyde.

    Protocol
  • Passage Stability

     PSMA PASSAGE

    Passage stability analysis of receptors expression by FACS.
    Flow cytometry surface staining of human PSMA on HEK293/Human PSMA Stable Cell Line demonstrates consistent mean fluorescent intensity across passage 4-21.

    Protocol
*如有相关细胞池需求请联系我们

用户评价
发表评论

背景介绍

Prostate-specific membrane antigen (PSMA) is also known as Folate hydrolase 1 (FOLH1), Glutamate carboxypeptidase 2 (GCP2), N-acetylated-alpha-linked acidic dipeptidase I (NAALAD1), which belongs to the peptidase M28 family and M28B subfamily. FOLH1 / PSMA is stable at pH greater than 6.5. FOLH1 / PSMA is a type II transmembrane zinc metallopeptidase that is most highly expressed in the nervous system, prostate, kidney, and small intestine. FOLH1 / GCP-2 is homodimer and binds 2 zinc ions per subunit, and required for NAALADase activity. The catalytic activity of PSMA involved in releasing of an unsubstituted, C-terminal glutamyl residue, typically from Ac-Asp-Glu or folylpoly – gamma - glutamates. FOLH1 / GCP-2 / PSMA has both folate hydrolase and N – acetylated – alpha – linked - acidic dipeptidase (NAALADase) activity and has a preference for tri-alpha-glutamate peptides. GCP-2 / PSMA involved in prostate tumor progression and also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.

前沿进展

 
药物研发进展
  • 英文全称:

    Prostate-Specific Membrane Antigen

  • 中文全称:

    前列腺癌特异性膜抗原

  • 种类:

  • 上市药物数量:

    5 详情

  • 临床药物数量:

    102 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍